Skip Nav Destination
1-5 of 5
Clin Sci (Lond) (2005) 108 (6): 547–552.
Published: 24 May 2005
...He-Hui XIE; Fu-Ming SHEN; Yong-Bing CAO; Hui-Lin LI; Ding-Feng SU The present study was designed to investigate the effects of low-dose ketanserin on BPV (blood pressure variability), BRS (baroreflex sensitivity) and organ damage in SHR (spontaneously hypertensive rats). Ketanserin was mixed in rat...
Clin Sci (Lond) (1984) 66 (4): 443–451.
Published: 01 April 1984
... ketanserin nearly abolished the contractile responses produced by addition of the platelets 20 min after aggregation, and significantly reduced those produced by addition of the platelets 1 min after aggregation. 5. Ketanserin did not affect the contractile responses of the arteries to potassium chloride...
Robert Fagard, Anne Cattaert, Paul Lijnen, Jan Staessen, Luc Vanhees, Emmanuel Moerman, Antoon Amery
Clin Sci (Lond) (1984) 66 (1): 17–25.
Published: 01 January 1984
... antagonist ketanserin on another occasion. The effects of ketanserin on the components of the renin—angiotensin—aldosterone system, on plasma catecholamines and on exercise capacity for graded uninterrupted exercise were also investigated. 2. At rest in recumbency rapid intravenous injection of 10 mg...
Clin Sci (Lond) (1982) 63 (s8): 435s–438s.
Published: 01 October 1982
...G. J. Wenting; A. J. Man In 'T Veld; A. J. Woittiez; F. Boomsma; M. A. D. H. Schalekamp 1. The new peripherally acting selective 5-hydroxytryptamine receptor blocking agent ketanserin was given (10 mg intravenously) to 17 patients with essential hypertension. 2. Systemic mean systolic arterial...
Clin Sci (Lond) (1981) 61 (s7): 473s–476s.
Published: 01 December 1981
...J. De Crée; J. Leempoels; H. Geukens; W. De Cock; H. Verhaegen 1. In a double-blind placebo-controlled crossover study a 4 week treatment with ketanserin was shown to reduce systolic and diastolic blood pressure markedly and significantly in 10 patients with essential hypertension. Heart rate...